Informações:
Falhas:
ID
22920
Descrição
Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).; ODM derived from: https://clinicaltrials.gov/show/NCT00337779
Link
https://clinicaltrials.gov/show/NCT00337779
Palavras-chave
Versões (1)
- 16/06/2017 16/06/2017 -
Transferido a
16 de junho de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Relapsing Remitting Multiple Sclerosis NCT00337779
Eligibility Relapsing Remitting Multiple Sclerosis NCT00337779
- StudyEvent: Eligibility
Similar models
Eligibility Relapsing Remitting Multiple Sclerosis NCT00337779
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
age; non-small cell lung cancer
Item
males and females at least 18 years of age who have confirmed diagnosis of non-small cell lung cancer
boolean
C0001779 (UMLS CUI [1])
C0007131 (UMLS CUI [2])
C0007131 (UMLS CUI [2])
therapy systemic lung cancer
Item
patients with no systemic prior systemic treatment for lung cancer except patients at least 12 months from prior adjuvant therapy
boolean
C0087111 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0242379 (UMLS CUI [1,3])
C0205373 (UMLS CUI [1,2])
C0242379 (UMLS CUI [1,3])
organ function adequate; liver function
Item
adequate bone marrow,kidney and liver function
boolean
C0678852 (UMLS CUI [1,1])
C0205411 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0205411 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
major surgery; radiation
Item
must be recovered and at least 4 weeks from major surgery or radiation
boolean
C0679637 (UMLS CUI [1])
C0851346 (UMLS CUI [2])
C0851346 (UMLS CUI [2])
ecog
Item
ecog (eastern cooperative oncology group) performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
contraception status
Item
men and women must agree to use birth control during the study
boolean
C0420837 (UMLS CUI [1])
negative pregnancy test
Item
women able to have children must have a negative pregnancy test 14 days before study enrollment
boolean
C0427780 (UMLS CUI [1])
investigational agents
Item
patients with prior treatment with other investigational agents less than 4 weeks before study enrollment
boolean
C1875319 (UMLS CUI [1])
pregnancy; lactating
Item
pregnant or nursing female patients
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
C0006147 (UMLS CUI [1,2])
hiv positive
Item
patients who are hiv positive
boolean
C0019699 (UMLS CUI [1])
hepatitis
Item
patients who have hepatitis a, b, or c
boolean
C0019158 (UMLS CUI [1])
Oral Route of Drug administration
Item
patients unable to take study medication by mouth
boolean
C1527415 (UMLS CUI [1])
brain cancer
Item
patients with untreated brain cancer
boolean
C0153633 (UMLS CUI [1])
bevacizumab
Item
patient eligible for treatment with bevacizumab and for whom bevacizumab is available
boolean
C0796392 (UMLS CUI [1])